Mayo Clinic’s Dr. James Ingle Recognized for Breast Cancer Research

Mayo Clinic’s Dr. James Ingle Recognized for Breast Cancer Research
World-renowned expert on breast cancer, Dr. James Ingle, attended the 37th San Antonio Breast Cancer Symposium yesterday, December 10, to receive the 2014 William L. McGuire Memorial Lecture Award and gave a memorial lecture titled, “Pharmacogenomics in the Quest for Precision Endocrine Therapy of Breast Cancer”. Dr. Ingle was selected by the SABCS Executive and Planning Committees among persons nominated by prominent researchers in the field. He is widely known for his clinically impactful research on two chief endocrine breast cancer treatments: tamoxifen and aromatase inhibitors. Just recently, Dr. Ingle took on a leadership role in the Mayo Clinic Pharmacogenomic Research Network to oversee multiple genome-wide association studies to investigate genetic variability in patients’ response to these two endocrine treatments, as well as chemotherapy - a project essential to advance precision medicine that focuses on individualized treatments. Dr. Ingle is also involved in the identification of genetic biomarkers that can predict which breast cancer patients are more likely to benefit from selective
Subscribe or to access all post and page content.